With glutathione treatments, you can see: Overall lighter, brighter skin tone
This means that after neutralizing free radicals, it helps restore and recharge other antioxidants, making the bodys defense system even stronger
What's Next: Orforglipron (oral GLP-1) completing Phase 3 trials with submissions expected by year-end 2025 CEO Dave Ricks expects FDA approval by March 2026 International launches accelerating in China, Brazil, India, and Mexico The GLP-1 market is projected to exceed $100B+ by the early 2030s, and Lilly is positioned as the category leader
Low-purity peptides often contain residual salts, synthetic byproducts, or other contaminants
Severe dehydration combined with semaglutide's effects on fluid balance can lead to dizziness, electrolyte imbalances, and decreased medication effectiveness
Regulatory submission for retatrutide is expected in 2026